Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

Keynote webinar | Spotlight on medication adherence

LIVE: Thursday 27th June 2024, 18:00-19:30 (CEST)
Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.
ADVANCED SEARCH
Log in
Top
Digestive Diseases and Sciences
Published in: Digestive Diseases and Sciences 9/2007

01-09-2007 | Original Paper

Colonization and Impact of Disease and Other Factors on Intestinal Microbiota

Authors: Oscar C. Thompson-Chagoyán, José Maldonado, Angel Gil

Published in: Digestive Diseases and Sciences | Issue 9/2007

Login to get access

Abstract

The aim of this study was to review the process of microbial colonization and the environmental and host factors that influence colonization and microbial succession. The impact of some diseases on intestinal microbiota composition is also described. Microbial colonization of the gut by maternal vaginal and fecal bacteria begins during and after birth. During the first 2 years of life, specific microbes become established in a process designated microbial succession. Microbial succession in the gastrointestinal tract is influenced by numerous external and internal host-related factors, and by the second year of life, the intestinal microbiota composition is considered identical to that of adults. Nevertheless, intestinal microbiota in both infants and adults remain incompletely characterized and their diversity poorly defined. The main explanation is that many intestinal bacteria that live in an anaerobic environment are difficult or impossible to culture outside the intestine. However, recent advances in molecular biology techniques have initiated the description of new bacteria species. The composition of gut microbiota can be modulated by host, environmental, and bacterial factors, and strong evidence has emerged of substantial modifications during illness or exposure to threatening experiences. It has been postulated that improvements in hygienic measures have led to an increase in allergic diseases (“hygiene hypothesis”). Alterations in gut microbiota and their functions have been widely associated with many chronic and degenerative diseases, including inflammatory bowel disease, colon cancer, and rheumatoid arthritis.
Literature
1.
Mackie RI, Sghir A, Gaskins HR (1999) Developmental microbial ecology of neonatal gastrointestinal tract. Am J Clin Nutr 69(Suppl):1035–1045
2.
Gismondo MR, Drago L, Lombardi A (1999) Review of probiotics available to modify gastrointestinal microbiota. Int J Antimicrob Agents 12:287–292PubMedCrossRef
3.
Isolauri E, Kirjavainen PV, Salminen S (2002) Probiotics: A role in the treatment of intestinal infection and inflammation? Gut 50(Suppl):54–59
4.
Isolauri E (2001) Probiotics in human disease. Am J Clin Nutr 73(Suppl):1142–1146
5.
Teitelbaum JE, Walker WA (2002) Nutritional impact of pre- and probiotics as protective gastrointestinal organisms. Annu Rev Nutr 22:107–138PubMedCrossRef
6.
Bezirtzoglou E (1997) The intestinal microbiota during the first weeks of life. Anaerobe 3:173–177PubMedCrossRef
7.
McFarland LV (2000) Normal microbiota: diversity and functions. Microb Ecol Health Dis 12:193–207CrossRef
8.
Kleesen B, Bezirtzoglou E, Matto J (2000) Cultured-based knowledge on biodiversity, development and stability of human gastrointestinal microbiota. Microb Ecol Health Dis 2(Suppl):53–63CrossRef
9.
Walker WA, Duffy LC (1998) Diet and bacterial colonization: role of probiotics. J Nutr Biochem 9:668–675CrossRef
10.
Thompson-Chagoyán OC, Maldonado J, Gil A (2004) La microbiota intestinal en el niño y la influencia de la dieta sobre su composición. Alim Nutr Salud 11:37–48
11.
Eckburg PB, Bik EM, Bernstein CN, Purdom E, Dethlefsen L, Sargent M (2005) Diversity of the human intestinal microbial microbiota. Science 308:1635–1638PubMedCrossRef
12.
Lay C, Rigottier-Gois L, Holmstrøm K, et al. (2005) Colonic microbiota signatures across five northern European countries. Appl Environ Microbiol 71:4153–4155PubMedCrossRef
13.
Seksik P, Rigottier-Gois L, Gramet G, Sutren M, Pochart P, Marteau P, Jian R, Dore J (2003) Alterations of the dominant faecal bacterial groups in patients with Crohn's disease of the colon. Gut 52:237–242PubMedCrossRef
14.
Suau A, Bonnet R, Sutren M, Godon JJ, Gibson GR, Collins MD, Dore J (1999) Direct analysis of genes encoding 16S rRNA from complex communities reveals many novel molecular species within the human gut. Appl Environ Microbiol 65:4799–4807PubMed
15.
Zoetendal EG, Akkermans AD, De Vos WM (1998) Temperature gradient gel electrophoresis analysis of 16S rRNA from human fecal samples reveals stable and host-specific communities of active bacteria. Appl Environ Microbiol 64:3854–3859PubMed
16.
Rigottier-Gois, L, Le Bourhis AG, Gramet G, Rochet V, Dore J (2003) Fluorescent hybridisation combined with flow cytometry and hybridisation of total RNA to analyse the composition of microbial communities in human feces using 16S rRNA probes. FEMS Microbiol Ecol 43:237–245CrossRefPubMed
17.
Ley RE, Backhed F, Turnbaugh P, Lozupone CA, Knight RD, Gordon JI (2005) Obesity alters gut microbial ecology. Proc Natl Acad Sci USA 102:11070–11075PubMedCrossRef
18.
Franks AH, Harmsen HJ, Raangs GC, Jansen GJ, Schut F, Welling GW (1998) Variations of bacterial populations in human feces measured by fluorescent in situ hybridization with group-specific 16S rRNA-targeted oligonucleotide probes. Appl Environ Microbiol 64:3336–3345PubMed
19.
Harmsen HJ, Raangs GC, He T, Degener JE, Welling GW (2002) Extensive set of 16S rRNA-based probes for detection of bacteria in human feces. Appl Environ Microbiol 68:2982–2990PubMedCrossRef
20.
Hayashi H, Sakamoto M, Benno Y (2002) Phylogenetic analysis of the human gut microbiota using 16S rDNA clone libraries and strictly anaerobic culture-based methods. Microbiol Immunol 46:535–548PubMed
21.
22.
Wang X, Heazlewood SP, Krause DO, Florin TH (2003) Molecular characterization of the microbial species that colonize human ileal and colonic mucosa by using 16S rDNA sequence analysis. J Appl Microbiol 95:508–520PubMedCrossRef
23.
Collins MD, Gibson GR (1999) Probiotics, prebiotics and synbiotics: approaches for modulating the microbial ecology of the gut. Am J Clin Nutr 69(Suppl):1052–1057
24.
Brook I, Barret C, Brinkman C, Martin W, Finegold S (1979) Aerobic and anaerobic bacterial microbiota of the maternal cervix and newborn gastric fluid and conjuntiva: a prospective study. Pediatrics 63:451–455PubMed
25.
Long SS, Swenson RM (1977) Development of anaerobic fecal microbiota in healthy newborn infants. J Pediatr 91:298–301PubMedCrossRef
26.
Gewolb IH, Schwalbe RS, Taciak VL, Harrison TS, Panigrahi P (1999) Stool microbiota in extremely low birthweight infants. Arch Dis Child 80:F167–F173
27.
Yoshioka H, Iseki K, Fujita K (1983) Development and differences of intestinal microbiota in the neonatal period in breast-fed and bottle-fed infants. Pediatrics 72:317–321PubMed
28.
Harmsen HJ, Wildeboer-veloo AC, Raangs GC, Wagendorp AA, Klijn N, Bindels JG, Welling GW (2000) Analysis of intestinal development in breast-fed and formula-fed infants by using molecular identification and detection methods. J Pediatr Gastroenterol Nutr 30:61–67PubMedCrossRef
29.
Asquith MT, Harrod JR (1979) Reduction in bacterial contamination in banked human milk. J Pediatr 95:993–994PubMedCrossRef
30.
West PA, Hewitt JH, Murphy OM (1979) The influence of methods of collection and storage on the bacteriology of human milk. J Appl Bacteriol 46:269–277PubMed
31.
Grönlund MM, Arvilommi H, Kero P, Lehtonen OP, Isolauri E (2000) Importance of intestinal colonization in the maturation of humoral immunity in early infancy: a prospective follow up study of healthy infants aged 0–6 months. Arch Dis Child 83:F186–F192
32.
Benno Y, Sawada K, Mitsuoka T (1984) The intestinal microbiota of infants: composition of fecal microbiota in breast-fed and bottle-fed infants. Microbiol Immunol 28:975–986PubMed
33.
Bengmark S (2000) Colonic food: pre- and probiotics. Am J Gastroenterol 95(Suppl):5–7CrossRef
34.
Orskov F, Sorensen KB (1975) Escherichia coli serogroups in breast-fed and bottle fed infants. Acta Pathol Microbiol Scand 83:25–30
35.
Rubaltelli FF, Biadaioli R, Pecile P, Nicoletti P (1998) Intestinal microbiota in breast-fed and bottle-fed infants. J Perinat Med 26:186–191PubMedCrossRef
36.
Stark PL, Lee A (1982) The microbial ecology of the large bowel of breast-fed and formula-fed infants during the first year of life. J Med Microbiol 15:189–203PubMedCrossRef
37.
Salminen S, Bouley C, Boutron-Ruault MC, Cummings JH, Franck A, Gibson GR, Isolauri E, Moreau MC, Roberfroid M, Rowland I (1998) Functional food science and gastrointestinal physiology and fuction. Br J Nutr 80(Suppl):147–171CrossRef
38.
39.
Bennet R, Eriksson M, Nord CE, Zetterstrom R (1986) Fecal bacterial microbiota of newborn infants during intensive care management and treatment with five antibiotic regimens. Pediatr Infect Dis J 5:533–539CrossRef
40.
Goldman DA, Leclair J, Macone A (1978) Bacterial colonization of neonates admitted to an intensive care environment. J Pediatr 93:288–293CrossRef
41.
Akata H, Yoshioka H, Fujita K (1985) Development of the intestinal microbiota in very low birth weight infants compared to normal full-term infants. Eur J Pediatr 144:186–190CrossRef
42.
Hall MA, Cole CB, Smith SL, Fuller R, Rolles CJ (1990) Factors influencing the presence of fecal lactobacilli in early infancy. Arch Dis Child 65:185–188PubMedCrossRef
43.
Fanaro S, Chierici R, Guerrini P, Vigi V (2003) Intestinal microbiota in early infancy: composition and development. Acta Paediatr Suppl 441:48–55
44.
Simon GL, Gorbach SL (1984) Intestinal microbiota in health and disease. Gastroenterology 86:174–193PubMed
45.
Mitsuoka T (1982) Recent trends in research on intestinal microbiota. Bifidobacteria Microbiota 1:3–24
46.
Hentges DJ (1993) The anaerobic microbiota of the human body. Clin Infect Dis 6(Suppl):175–180
47.
48.
Vanderhoof JA (2000) Probiotics and intestinal inflammatory disorders in infants and children. J Pediatr Gastroenterol Nutr 30(Suppl):34–38CrossRef
49.
Guérin-Danan C, Popot AF, Vaissade CP, Gaudichon C, Pedone C, Bouley C, Szylit O (1997) Pattern of metabolism and composition of the fecal microbiota in infants 10 to 18 months old from day care centers. J Pediatr Gastroenterol Nutr 25:281–289PubMedCrossRef
50.
51.
Hooper LV, Wong MH, Thelin A, Hansson L, Falk PG, Gordon JI (2001) Molecular analysis of commensal host-microbial relationships in the intestine. Science 291:881–884PubMedCrossRef
52.
Saavedra JM (1995) Microbes to fight microbes: a not so novel approach to controlling diarrheal disease. J Pediatr Gastroenterol Nutr 21:125–129PubMedCrossRef
53.
Vandenplas Y (2004) Clinical overview: the changing pattern of clinical aspects of allergy diseases. Nestlé Nutr Workshop 53:1–25
54.
Smit JJ, Folkerts G, Nijkamp FP (2004) Mycobacteria, genes and the hygiene hypothesis. Curr Opin Allergy Clin Immunol 4:57–62PubMedCrossRef
55.
Rautava S, Ruuskanen O, Ouwehand A, Salminen S, Isolauri E (2004) The hygiene hypothesis of atopic disease—an extended version. J Pediatr Gastroenterol Nutr 38:378–388PubMedCrossRef
56.
Kalliomaki M, Kirjavainen P, Eerola E, Kero P, Salminen S, Isolauri E (2001) Distinct patterns of neonatal gut microbiota in infants in whom atopy was and was not developing. J Allergy Clin Immunol 107:129–134PubMedCrossRef
57.
Bjorksten B, Naaber P, Sepp E, Mikelsaar M (1999) The intestinal microbiota in allergic Estonian and Swedish 2-year-old children. Clin Exp Allergy 29:342–346PubMedCrossRef
58.
He F, Ouwehan A, Isolauri E, Hashimoto H, Benno Y, Salminen S (2001) Comparison of mucosal adhesion and species identification of bifidobacteria isolated from healthy and allergic infants. FEMS Immunol Med Microbiol 30:43–47PubMedCrossRef
59.
Schultz M, Scholmerich J, Rath HC (2003) Rationale for probiotic and antibiotic treatment strategies in inflammatory bowel diseases. Dig Dis Sci 21:105–128CrossRef
60.
Swidsinski A, Ladhoff A, Pernthaler A, Swidsinski S, Loening-Baucke V, Ortner M, Weber J, Hoffmann U, Schreiber S, Dietel M, Lochs H (2002) Mucosal microbiota in inflammatory bowel disease. Gastroenterology 122:44–54PubMedCrossRef
61.
Thompson-Chagoyán OC, Maldonado J, Gil A (2005) Aetiology of inflammatory bowel disease (IBD): role of intestinal microbiota and gut-associated lymphoid tissue immune response. Clin Nutr 24:339–352PubMedCrossRef
62.
Kennedy RJ, Kirk SJ, Gardiner KR (2000) Promotion for a favorable gut microbiota in inflammatory bowel disease. J Parent Ent Nutr 24:189–195CrossRef
63.
Borruel N, Carol M, Casellas F, Antolin M, de Lara F, Espin E, Naval J, Guarner F, Malagelada JR (2002) Increased mucosal TNF-α production in Crohn's disease can be modulated in vitro by probiotic bacteria. Gut 5:659–664CrossRef
64.
Steidler L (2001) Microbiological and immunological strategies for treatment of inflammatory bowel disease. Microbes Infect 3:1157–1166PubMedCrossRef
65.
Keighley MR. Arabi Y, Dimock F Burdon DW, Allan RN, Alexander-Williams J (1978) Influence of inflammatory bowel disease on intestinal microbiota. Gut 19:1099–1104PubMed
66.
Schultsz C Van Den Berg FM, Ten Kate FW, Tytgat GN, Dankert J (1999) The intestinal mucus layer from patients with inflammatory bowel disease harbors high numbers of bacteria compared with controls. Gastroenterology 117:1089–1097PubMedCrossRef
67.
Hooper LV, Midvedt T, Gordon JI (2002) How host microbial interactions shape the nutrient environment of mammalian intestine. Annu Rev Nutr 22:283–307PubMedCrossRef
68.
Backhed F, Ding H, Wang T, Hooper LV, Koh GY, Nagy A, Semenkovich CF, Gordon JI (2004) The gut microbiota as an environmental factor that regulates fat storage. Proc Natl Acad Sci USA 101:15718–15723PubMedCrossRef
69.
Backhed F, Ley RE, Sonnenburg JL, Peterson DA, Gordon JI (2005) Host-bacterial mutualism in the human intestine. Science 307:1915–1920PubMedCrossRef
70.
Bingham SA (1999) High meat diets and cancer risk. Proc Nutr Soc 58:243–248PubMed
71.
Rafter J, Glinghammar B (1998) Interactions between the environment and genes in the colon. Eur J Cancer Prev 7(Suppl):69–74CrossRef
72.
Midtvedt T (1987) Intestinal bacteria and rheumatic disease. Scand J Rheumatol Suppl 64:49–54PubMed
73.
Toivanen P (2003) Normal intestinal microbiota in the aetiopathogenesis of rheumatoid arthritis. Ann Rheum Dis 62:807–811PubMedCrossRef
74.
Granfors K, Jalkanen S, von Essen R, Lahesmaa-Rantala R, Isomaki O, Pekkola-Heino K, Merilahti-Palo R, Saario R, Isomaki H, Toivanen A (1989) Yersinia antigens in synovial-fluid cells from patients with reactive arthritis. N Engl J Med 320:216–221PubMedCrossRef
75.
Granfors K, Jalkanen S, Lindberg AA, Mäki-Ikola O, von Essen R, Lahesmaa-Rantala R, Isomaki H, Saario R, Arnold WJ, Toivanen A (1990) Salmonella lipopolysaccharide in synovial cells from patients with reactive arthritis. Lancet 335:685–688PubMedCrossRef
76.
Kjeldsen-Kragh J (1999) Rheumatoid arthritis treated with vegetarian diets. Am J Clin Nutr 70(Suppl):594–600
77.
Eerola E, Mottonen T, Hannonen P, Luukkainen R, Kantola I, Vuori K, Tuominen J, Toivanen P (1994) Intestinal microbiota in early rheumatoid arthritis. Br J Rheumatol 33:1030–1038PubMedCrossRef
78.
Grönlund MM, Lehtonen Op, Eerola E, Kero P (1999) Fecal microflora in healthy infants born by different methods of delivery: permanent changes in intestinal microbiota after caesarean delivery. J Pediatr Gastroenterol Nutr 28:19–25PubMedCrossRef
79.
Bailey MT, Coe CL (1999) Maternal separation disrupts the integrity of the intestinal microbiota in infant rhesus monkeys. Dev Psychobiol 35:146–155PubMedCrossRef
80.
Hawrelak JA, Myers SP (2004) The causes of intestinal dysbiosis: a review. Altern Med Rev 9:180–197PubMed
81.
Holdeman LV, Good IJ, Moore WE (1976) Human fecal microbiota: variation in bacterial composition within individuals and a possible effect of emotional stress. Appl Environ Microbiol 31:359–375PubMed
82.
Lyte M, Ernst S (1992) Catecholamine induced growth of Gram negative bacteria. Life Sci 50:203–212PubMedCrossRef
83.
Lyte M, Frank CD, Green BT (1996) Production of autoinducer of growth by norepinephrine cultured Escherichia coli 0157:H7. FEMS Microbiol Lett 139:155–159PubMed
84.
Freestone PP, Haigh RD, Williams PH, Lyte M (1999) Stimulation of bacterial growth by heat-stable, norepinephrine-induced autoinducers. FEMS Microbiol Lett 172:53–60PubMedCrossRef
85.
Dendukuri N, Costa V, McGregor M, Brophy JM (2005) Probiotic therapy for the prevention and treatment of Clostridium difficile-associated diarrhea: a systematic review. CMAJ 173:167–170PubMed
86.
Surawicz CM (2005) Antibiotic-associated diarrhea and pseudomembranous colitis: are they less common with poorly absorbed antimicrobials. Chemotherapy 51(Suppl 1):81–89PubMedCrossRef
87.
Poutanen SM, Simor AE (2004) Clostridium difficile-associated diarrhea in adults. CMAJ 171:51–58PubMed
88.
Muto CA, Pokrywka M, Shutt K, Mendelsohn AB, Nouri K, Posey K, Roberts T, Croyle K, Krystofiak S, Patel-Brown S, Pasculle AW, Paterson DL, Saul M, Harrison LH (2005) A large outbreak of Clostridium difficile-associated disease with an unexpected proportion of deaths and colectomies at a teaching hospital following increased fluoroquinolone use. Infect Control Hosp Epidemiol 26:273–280PubMedCrossRef
Metadata
Title
Colonization and Impact of Disease and Other Factors on Intestinal Microbiota
Authors
Oscar C. Thompson-Chagoyán
José Maldonado
Angel Gil
Publication date
01-09-2007
Publisher
Springer US
Published in
Digestive Diseases and Sciences / Issue 9/2007
Print ISSN: 0163-2116
Electronic ISSN: 1573-2568
DOI
https://doi.org/10.1007/s10620-006-9285-z

Other articles of this Issue 9/2007

Digestive Diseases and Sciences 9/2007 Go to the issue

Original Paper

Reproducibility of 24-Hour Combined Multiple Intraluminal Impedance (MII) and pH Measurements in Infants and Children. Evaluation of a Diagnostic Procedure for Gastroesophageal Reflux Disease

Letter to the Editor

Molecular Analysis of the p53 Gene in Patients with Intestinal Metaplasia of the Cardia and Barrett's Esophagus: Characterization by Sequencing

Original Paper

Levels of Hepatitis B Virus (HBV) Replication During the Nonreplicative Phase: HBV Quantification by Real-Time PCR in Korea

OriginalPaper

Nimesulide Inhibits Crypt Epithelial Cell Proliferation at 6 Hours in the Small Intestine in CD-1 Mice

Original Paper

Enhanced Sensitivity to CD95-Induced Apoptosis in ob/ob Mice

OriginalPaper

Lactobacillus plantarum 299v Enhances the Concentrations of Fecal Short-Chain Fatty Acids in Patients with Recurrent Clostridium difficile-Associated Diarrhea
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Reserve your place

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

Read more

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine
Image Credits